BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ArQule, Inc. 

19 Presidential Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-994-0300 Fax: 781-376-6019


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery

Collaborations

Roche 

Pfizer Inc. 

Daiichi Sankyo, Inc. 





 Company News
ArQule, Inc. (ARQL) To Present At Needham 13th Annual Healthcare Conference 4/2/2014 7:45:15 AM    More...
ArQule, Inc. (ARQL) Reports Fiscal 2013 Year End And Fourth Quarter Results 3/5/2014 9:01:20 AM    More...
ArQule, Inc. (ARQL) To Report Fiscal 2013 Financial Results On March 5, 2014 2/26/2014 7:39:48 AM    More...
ArQule, Inc. (ARQL) To Present At RBC Capital Markets Healthcare Conference 2/18/2014 6:46:17 AM    More...
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014 9:46:24 AM    More...
ArQule, Inc. (ARQL) Soars As FDA Panel Favors Continuation Of Liver Cancer Drug Study, Stock Up +6.78% At Market Close (January 17, 2014) 1/17/2014 8:28:01 AM    More...
ArQule, Inc. (ARQL) Announces Third Quarter Fiscal 2013 Results 11/7/2013 8:07:14 AM    More...
ArQule, Inc. (ARQL) to Report Third Quarter 2013 Financial Results on November 7, 2013 10/31/2013 8:24:52 AM    More...
ArQule, Inc. (ARQL) Release: Data Presented at European Cancer Congress Suggest Clinical Benefit of Tivantinib in Patients With MET High Non-Squamous Non-Small Cell Lung Cancer 9/30/2013 9:53:46 AM    More...
ArQule, Inc. (ARQL) Release: Data Presented at European Cancer Congress Suggest Clinical Benefit of Tivantinib in Patients with MET High Non-Squamous Non-Small Cell Lung Cancer 9/30/2013 7:00:55 AM    More...
12345678910...

//-->